Optovite B12 (Cyanocobalamin)

Cyanocobalamin serves as a cofactor for the enzymes methionine synthase and methylmalonyl‑CoA mutase. These enzymes are essential for DNA synthesis, red blood cell formation, and myelin production. By facilitating these biochemical pathways, cyanocobalamin helps correct the metabolic disturbances caused by B12 deficiency.

The appropriate dose of Optovite B12 is determined by the prescribing healthcare professional based on the patient’s clinical condition, severity of deficiency, and route of administration. Dosage regimens may differ for oral, intramuscular, or intravenous use and should follow the prescriber’s instructions.

Vitamin B12 is an essential nutrient during pregnancy and lactation. While cyanocobalamin is generally considered safe, the decision to use Optovite B12 should be made by a qualified healthcare provider who can evaluate the benefits and any potential risks for the mother and infant.

To request Optovite B12, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will verify trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Optovite B12 contains cyanocobalamin, a stable and widely used form of vitamin B12. Compared with other B12 preparations such as methylcobalamin or hydroxocobalamin, cyanocobalamin is often chosen for its cost‑effectiveness and proven efficacy in correcting deficiency, though specific clinical situations may favor alternative forms.

Optovite B12 should be stored at temperatures below 25 °C, in its original packaging, protected from moisture and direct light. Proper storage maintains product stability and potency throughout its shelf life.

Optovite B12 can be given orally as tablets or liquid, intramuscularly via injection, or intravenously, depending on the formulation and clinical need. The route and frequency are determined by the prescribing clinician based on the patient’s condition.

Serious adverse reactions, although rare, include anaphylaxis, severe hypersensitivity, thrombophlebitis at the injection site, and serum‑sickness‑like symptoms. Patients should seek immediate medical attention if they experience signs of a severe allergic reaction such as difficulty breathing, swelling, or rash.

Optovite B12 should be avoided in individuals with a known hypersensitivity to cyanocobalamin or any excipients in the formulation. Patients with certain medical conditions should consult their healthcare provider before starting therapy.